Nano-X Imaging (NNOX) Cash & Equivalents (2019 - 2026)

Nano-X Imaging (NNOX) has reported Cash & Equivalents for 8 consecutive years, with $43.9 million the latest figure, recorded in Q1 2026.

• Quarterly Cash & Equivalents rose 8.62% year-over-year to $43.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.9 million (up 8.62% YoY) and the FY2025 annual result came in at $49.2 million, up 25.05% from the prior year.
• Cash & Equivalents declined to $43.9 million in Q1 2026 per NNOX's latest filing, from $49.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for NNOX reached as high as $66.8 million in Q1 2022 and fell as low as $38.5 million in Q4 2022.
• A 5-year average of $51.7 million and a median of $49.9 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 69.55% — and 2023, when it soared 46.57%.
• Year by year, Cash & Equivalents stood at $38.5 million in 2022, then surged by 46.57% to $56.4 million in 2023, then slumped by 30.28% to $39.3 million in 2024, then gained by 25.05% to $49.2 million in 2025, then decreased by 10.77% to $43.9 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $43.9 million, $49.2 million, and $45.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.